Trends are set by those who succeed in the market. BioGeneriX AG, founded in June 2000, acts independently - yet strongly supported by its shareholder ratiopharm - to develop multiscource proteins for established markets. BioGeneriX is a 100% daughter company of ratiopharm, Europe's premier generic drug company. Ratiopharm was founded in 1974 for the express purpose of building a new market with a longterm future. Targeted marketing, technical innovations and above all, a well-rounded product portfolio continue to play a part in raising acceptance of generics in medical circles and among patients. Ratiopharm is part of the Merckle Group. Founded in 1881, Merckle is already in its fourth generation of successful family management. Now the company is looking to the future, securing its market share through the quality of its research and development, and strong sales and marketing organization.